Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A
Critical Review and Practical Consideration

J 2022

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration

BURKOŇ, Petr, Jan TRNA, Marek SLÁVIK, Radim NĚMEČEK, Tomáš KAZDA et. al.

Základní údaje

Originální název

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration

Autoři

BURKOŇ, Petr (203 Česká republika, domácí), Jan TRNA (203 Česká republika, garant, domácí), Marek SLÁVIK (703 Slovensko, domácí), Radim NĚMEČEK (203 Česká republika, domácí), Tomáš KAZDA (203 Česká republika, domácí), Petr POSPÍŠIL (203 Česká republika, domácí), Milan DASTYCH (203 Česká republika, domácí), Michal EID (203 Česká republika, domácí), Ivo NOVOTNY (203 Česká republika), Tomáš PROCHÁZKA (203 Česká republika, domácí) a Miroslav VRZAL (203 Česká republika)

Vydání

Biomedicines, Basel, MDPI, 2022, 2227-9059

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.700

Kód RIV

RIV/00216224:14110/22:00127201

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.3390/biomedicines10102480

UT WoS

000872249300001

Klíčová slova anglicky

pancreatic neoplasms; neoadjuvant therapy; stereotactic body radiotherapy; review

Štítky

14110212, 14110213, 14110811, 14110812, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 5. 4. 2023 13:51, Mgr. Tereza Miškechová

Anotace

V originále

Pancreatic cancer is the third leading cause of cancer death in the developed world and is predicted to become the second by 2030. A cure may be achieved only with surgical resection of an early diagnosed disease. Surgery for more advanced disease is challenging and can be contraindicated for many reasons. Neoadjuvant therapy may improve the probability of achieving R0 resection. It consists of systemic treatment followed by radiation therapy applied concurrently or sequentially with cytostatics. A novel approach to irradiation, stereotactic body radiotherapy (SBRT), has the potential to improve treatment results. SBRT can deliver higher doses of radiation to the tumor in only a few treatment fractions. It has attracted significant interest for pancreatic cancer patients, as it is completed quickly, requires less time away from full-dose chemotherapy, and is well-tolerated than conventional radiotherapy. In this review, we aim to provide the reader with a basic overview of current evidence for SBRT indications in the treatment of pancreatic tumors. In the second part of the review, we focus on practical information with respect to SBRT treatment plan preparation the performance of such therapy. Finally, we discuss future directions related to the use of magnetic resonance linear accelerators.

Návaznosti

90125, velká výzkumná infrastruktura

Název: BBMRI-CZ III

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Citovat

BURKOŇ, Petr, Jan TRNA, Marek SLÁVIK, Radim NĚMEČEK, Tomáš KAZDA, Petr POSPÍŠIL, Milan DASTYCH, Michal EID, Ivo NOVOTNY, Tomáš PROCHÁZKA a Miroslav VRZAL. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. Biomedicines. Basel: MDPI, 2022, roč. 10, č. 10, s. 1-23. ISSN 2227-9059. Dostupné z: https://dx.doi.org/10.3390/biomedicines10102480.

@article{2233281,
   author = {Burkoň, Petr and Trna, Jan and Slávik, Marek and Němeček, Radim and Kazda, Tomáš and Pospíšil, Petr and Dastych, Milan and Eid, Michal and Novotny, Ivo and Procházka, Tomáš and Vrzal, Miroslav},
   article_location = {Basel},
   article_number = {10},
   doi = {http://dx.doi.org/10.3390/biomedicines10102480},
   keywords = {pancreatic neoplasms; neoadjuvant therapy; stereotactic body radiotherapy; review},
   language = {eng},
   issn = {2227-9059},
   journal = {Biomedicines},
   title = {Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration},
   url = {https://www.mdpi.com/2227-9059/10/10/2480},
   volume = {10},
   year = {2022}
}

TY  - JOUR
ID  - 2233281
AU  - Burkoň, Petr - Trna, Jan - Slávik, Marek - Němeček, Radim - Kazda, Tomáš - Pospíšil, Petr - Dastych, Milan - Eid, Michal - Novotny, Ivo - Procházka, Tomáš - Vrzal, Miroslav
PY  - 2022
TI  - Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration
JF  - Biomedicines
VL  - 10
IS  - 10
SP  - 1-23
EP  - 1-23
PB  - MDPI
SN  - 22279059
KW  - pancreatic neoplasms
KW  - neoadjuvant therapy
KW  - stereotactic body radiotherapy
KW  - review
UR  - https://www.mdpi.com/2227-9059/10/10/2480
N2  - Pancreatic cancer is the third leading cause of cancer death in the developed world and is predicted to become the second by 2030. A cure may be achieved only with surgical resection of an early diagnosed disease. Surgery for more advanced disease is challenging and can be contraindicated for many reasons. Neoadjuvant therapy may improve the probability of achieving R0 resection. It consists of systemic treatment followed by radiation therapy applied concurrently or sequentially with cytostatics. A novel approach to irradiation, stereotactic body radiotherapy (SBRT), has the potential to improve treatment results. SBRT can deliver higher doses of radiation to the tumor in only a few treatment fractions. It has attracted significant interest for pancreatic cancer patients, as it is completed quickly, requires less time away from full-dose chemotherapy, and is well-tolerated than conventional radiotherapy. In this review, we aim to provide the reader with a basic overview of current evidence for SBRT indications in the treatment of pancreatic tumors. In the second part of the review, we focus on practical information with respect to SBRT treatment plan preparation the performance of such therapy. Finally, we discuss future directions related to the use of magnetic resonance linear accelerators.
ER  -

BURKOŇ, Petr, Jan TRNA, Marek SLÁVIK, Radim NĚMEČEK, Tomáš KAZDA, Petr POSPÍŠIL, Milan DASTYCH, Michal EID, Ivo NOVOTNY, Tomáš PROCHÁZKA a Miroslav VRZAL. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. \textit{Biomedicines}. Basel: MDPI, 2022, roč.~10, č.~10, s.~1-23. ISSN~2227-9059. Dostupné z: https://dx.doi.org/10.3390/biomedicines10102480.

Podrobný výpis o publikaci